Adicet Bio, Inc.
ACET
Revenue
0.00
0.000.00%
-Assets
268.84M
▼-24.25M▼-8.27%
3 Months ChangeLiabilities
33.73M
▼-560.00k▼-1.63%
3 Months ChangeFree Cash Flow
-23.09M
▲2.92M▲11.23%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0000950170-24-114839
2024-09-30
Form 8-K
ID: 0000950170-24-110166
2024-09-19
Form 8-K
ID: 0000950170-24-107988
2024-09-10
Form 8-K
ID: 0000950170-24-104915
2024-08-19
Form 8-K
ID: 0000950170-24-098485
2024-08-13
Form 10-Q
ID: 0000950170-24-095745
2024-08-13
Form 8-K
ID: 0000950170-24-095744
2024-07-08
Form 8-K
ID: 0000950170-24-081943
2024-06-24
Form 8-K
ID: 0000950170-24-076460
2024-06-07
Form 8-K
ID: 0000950170-24-070568